Fentanyl

Verify with FDA CVM →

694 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
694
Total Reports
147
Deaths Reported
2120.0%
Death Rate

Active Ingredients

Fentanyl

Administration Routes

TransdermalUnknownTopicalIntravenousOtherCutaneousIntramuscularOralIntradermalParenteral

Species Affected

Dog 597
Cat 66
Unknown 12
Human 9
Goat 3
Primate 2
Alpaca 2
Pig 2
Guinea Pig 1

Most Affected Breeds

Dog (unknown) 86
Retriever - Labrador 75
Domestic Shorthair 34
Crossbred Canine/dog 31
Unknown 24
Retriever - Golden 20
Dachshund (unspecified) 18
Chihuahua 18
Pit Bull 18
Boxer (German Boxer) 15

Most Reported Reactions

Anorexia 149
Vocalisation 112
Hypothermia 90
Vomiting 87
Death by euthanasia 87
Lethargy (see also Central nervous system depression in 'Neurological') 86
Sedation 85
Not eating 74
Other abnormal test result NOS 65
Lack of efficacy - NOS 64
Inappetence 62
Diarrhoea 59

Outcome Breakdown

Recovered/Normal
288 (42.4%)
Outcome Unknown
144 (21.2%)
Euthanized
86 (12.6%)
Ongoing
77 (11.3%)
Died
62 (9.1%)
Recovered with Sequela
23 (3.4%)

Data Summary

Metric Value
Total adverse event reports 694
Reports involving death 147
Case-fatality rate (reported events) 2120.0%
Distinct species in reports 9
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fentanyl Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 694 adverse event reports referencing Fentanyl, including 147 reports in which the animal died — a 2120.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Fentanyl. Reported administration routes include Transdermal, Unknown, Topical, Intravenous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fentanyl reports are Dog (597 reports), Cat (66 reports), Unknown (12 reports), with Dog accounting for the largest share. Within those species, Dog (unknown) (86), Retriever - Labrador (75), Domestic Shorthair (34) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fentanyl are Anorexia (149), Vocalisation (112), Hypothermia (90), Vomiting (87). Of the 680 reports with a coded outcome, Recovered/Normal is the leading category at 42.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fentanyl.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial